Edited Transcript of AKBA earnings conference call or presentation 12-Nov-19 2:00pm GMT [Yahoo! Finance News]
Akebia Therapeutics, Inc. (AKBA)
Last akebia therapeutics, inc. earnings: 3/10 07:49 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.akebia.com/investor-relations
Company Research
Source: Yahoo! Finance News
Edited Transcript of AKBA earnings conference call or presentation 12-Nov-19 2:00pm GMT It's incredibly energizing to all of us at Akebia to consider how close we are to the data readout and to the potential introduction of vadadustat into our renal-focused commercial engine. Anemia due to CKD is a disease that affects 5.7 million people in the U.S. Essentially, every organ in the body is affected by this disease, most notably the kidneys and heart. There are limitations to the current standard of care in treating and managing this disease, including the risk of cardiovascular events. Providing a new oral treatment option upon regulatory approval to patients and physicians, one with the potential to help address their unmet needs and possibly better their lives would represent an incredible opportunity to advance patient care, and that's exactly what we've set out to achieve. It's been a busy and exciting few months. First, we achieved the primary objective by strengthening our balanc
Show less
Read more
Impact Snapshot
Event Time:
AKBA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKBA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKBA alerts
High impacting Akebia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AKBA
News
- Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsPR Newswire
- Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business HighlightsPR Newswire
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
AKBA
Earnings
- 5/9/24 - In-Line
AKBA
Sec Filings
- 5/9/24 - Form 4
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- AKBA's page on the SEC website